Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Verweij

Showing results (461-470 of 655) with videos related to

Pageof 66
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1994
Phase II study with docetaxel (Taxotere) in advanced soft tissue sarcomas of the adult. EORTC Soft Tissue and Bone Sarcoma GroupQ G van Hoesel, J Verweij, G Catimel, et al.
European Journal of Cancer (Oxford, England : 1990)|July 4, 2006
Phase I and pharmacokinetic study of halofuginone, an oral quinazolinone derivative in patients with advanced solid tumoursM J A de Jonge, H Dumez, J Verweij, et al.
Seminars in Oncology|April 16, 1998
Docetaxel and ifosfamide in patients with advanced solid tumors: results of a phase I studyL C Pronk, D Schrijvers, J H Schellens, et al.
European Journal of Cancer (Oxford, England : 1990)|March 11, 2004
Real-time pharmacokinetics guiding clinical decisions; phase I study of a weekly schedule of liposome encapsulated paclitaxel in patients with solid tumoursO Soepenberg, A Sparreboom, M J A de Jonge, et al.
British Journal of Cancer|November 15, 2007
A phase Ib study of pertuzumab, a recombinant humanised antibody to HER2, and docetaxel in patients with advanced solid tumoursG Attard, J Kitzen, S P Blagden, et al.
Cancer Chemotherapy and Pharmacology|September 6, 2000
Carzelesin phase II study in advanced breast, ovarian, colorectal, gastric, head and neck cancer, non-Hodgkin's lymphoma and malignant melanoma: a study of the EORTC early clinical studies group (ECSG)N Pavlidis, S Aamdal, A Awada, et al.
Acta Tropica|March 25, 2014
Malaria among adult inpatients in two Tanzanian referral hospitals: a prospective studySemvua B Kilonzo, Erasmus Kamugisha, Jennifer A Downs, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 14, 2005
What is the role of dose-dense therapy?M E L van der Burg, A van der Gaast, I Vergote, et al.
Anti-Cancer Drugs|June 23, 1999
Phase I and pharmacologic study of the arotinoid Ro 40-8757 in combination with cisplatin and etoposide in patients with non-small cell lung cancerL van Zuylen, J H Schellens, S H Goey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2000
Phase I study of 3-week schedule of irinotecan combined with cisplatin in patients with advanced solid tumorsM J de Jonge, A Sparreboom, A S Planting, et al.
Pageof 66

Showing results (461-470 of 655) with videos related to

Sort By:
Pageof 66
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1994
Phase II study with docetaxel (Taxotere) in advanced soft tissue sarcomas of the adult. EORTC Soft Tissue and Bone Sarcoma GroupQ G van Hoesel, J Verweij, G Catimel, et al.
European Journal of Cancer (Oxford, England : 1990)|July 4, 2006
Phase I and pharmacokinetic study of halofuginone, an oral quinazolinone derivative in patients with advanced solid tumoursM J A de Jonge, H Dumez, J Verweij, et al.
Seminars in Oncology|April 16, 1998
Docetaxel and ifosfamide in patients with advanced solid tumors: results of a phase I studyL C Pronk, D Schrijvers, J H Schellens, et al.
European Journal of Cancer (Oxford, England : 1990)|March 11, 2004
Real-time pharmacokinetics guiding clinical decisions; phase I study of a weekly schedule of liposome encapsulated paclitaxel in patients with solid tumoursO Soepenberg, A Sparreboom, M J A de Jonge, et al.
British Journal of Cancer|November 15, 2007
A phase Ib study of pertuzumab, a recombinant humanised antibody to HER2, and docetaxel in patients with advanced solid tumoursG Attard, J Kitzen, S P Blagden, et al.
Cancer Chemotherapy and Pharmacology|September 6, 2000
Carzelesin phase II study in advanced breast, ovarian, colorectal, gastric, head and neck cancer, non-Hodgkin's lymphoma and malignant melanoma: a study of the EORTC early clinical studies group (ECSG)N Pavlidis, S Aamdal, A Awada, et al.
Acta Tropica|March 25, 2014
Malaria among adult inpatients in two Tanzanian referral hospitals: a prospective studySemvua B Kilonzo, Erasmus Kamugisha, Jennifer A Downs, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 14, 2005
What is the role of dose-dense therapy?M E L van der Burg, A van der Gaast, I Vergote, et al.
Anti-Cancer Drugs|June 23, 1999
Phase I and pharmacologic study of the arotinoid Ro 40-8757 in combination with cisplatin and etoposide in patients with non-small cell lung cancerL van Zuylen, J H Schellens, S H Goey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2000
Phase I study of 3-week schedule of irinotecan combined with cisplatin in patients with advanced solid tumorsM J de Jonge, A Sparreboom, A S Planting, et al.
Pageof 66